CoSara Diagnostics

Executive Summary

CoSara Diagnostics is an Indian biotech company specializing in real-time PCR-based molecular diagnostic kits and instruments. Founded in 2017 and headquartered in Ahmedabad, the company operates GMP-compliant manufacturing facilities and offers a broad portfolio including single-plex, multiplex, and viral-load assays for infectious disease detection. With a focus on cost-effective and rapid testing, CoSara addresses critical needs in viral and bacterial infections, serving the Indian healthcare market. The company is privately held with an estimated employee range of 50–200 and has achieved commercial stage, suggesting validated product-market fit and ongoing revenue generation. While specific financials are not disclosed, its presence in the competitive diagnostics space positions it for growth driven by increasing demand for molecular testing post-pandemic and India's push for self-reliance in diagnostics under the 'Make in India' initiative.

Upcoming Catalysts (preview)

• Q2 2026Launch of multiplex respiratory panel70% success
• Q4 2026Partnership with Indian state government for rural testing program50% success
• Q3 2026Regulatory approval for viral-load assay expansion (HIV/HBV/HCV)60% success